Back to Journals » Breast Cancer: Targets and Therapy » Volume 7

Safety and esthetic outcomes of therapeutic mammoplasty using medial pedicle for early breast cancer

Authors Roshdy S, Hussein O, Khater A, Zuhdy M, El-Hadaad H, Farouk O, Senbel A, Fathi A, Hamed E, Denewer A

Received 1 March 2015

Accepted for publication 30 March 2015

Published 7 July 2015 Volume 2015:7 Pages 173—178


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Pranela Rameshwar

Sameh Roshdy,1 Osama Hussein,1 Ashraf Khater,1 Mohammad Zuhdy,1 Hend A El-Hadaad,2 Omar Farouk,1 Ahmad Senbel,1 Adel Fathi,1 Emadeldeen Hamed,1 Adel Denewer1

1Department of Surgical Oncology, Mansoura Oncology Center, 2Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt

Background: Although therapeutic mammoplasty (TM) was introduced for treatment of localized ductal carcinoma in situ and invasive breast carcinoma (stages I and II) in females with large breast size, the suitability of medial pedicle TM for treatment of breast tumors at different locations has not been established. The objective of this study was to assess the safety and esthetic outcome of medial pedicle TM for breast tumors at different locations.
Methods: The study was conducted from February 2012 to July 2014. Consecutive patients with early breast carcinoma with medium- and large-sized breasts, with or without ptosis, who were offered medial pedicle TM were included in the study. Patients who were not candidates for breast-conserving surgery or those with tumors located along the medial pedicle were excluded. All patients received immediate postoperative adjuvant chemoradiotherapy.
Results: Thirty patients with a mean age of 48.5 years received medial pedicle TM in the breast harboring the tumor or, additionally, the other breast (N=14). The tumors were in the upper (60.0%), lower (26.7%), and lateral (13.3%) quadrants. Minor complications occurred in five cases (5/30, 16.7%) in the ipsilateral and in two (2/14, 14.3%) contralateral breasts. No wound dehiscence or areolar necrosis was recorded. A total of 22 (73.3%) patients were scored as excellent cosmesis. After a median follow-up of 20 months, no locoregional recurrence or distant metastases were observed.
Conclusion: TM using a medial pedicle is a safe and appealing technique among women with tumors at different locations.

Keywords: therapeutic mammoplasty, medial pedicle, breast cancer, mastectomy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other article by this author:

Tumescent mastectomy: the current indications and operative tips and tricks

Khater A, Mazy A, Gad M, Taha Abd Eldayem O, Hegazy M

Breast Cancer: Targets and Therapy 2017, 9:237-243

Published Date: 30 March 2017

Readers of this article also read:

Identification of genes involved in breast cancer and breast cancer stem cells

Apostolou P, Toloudi M, Papasotiriou I

Breast Cancer: Targets and Therapy 2015, 7:183-191

Published Date: 15 July 2015

Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis

Frugtniet B, Jiang WG, Martin TA

Breast Cancer: Targets and Therapy 2015, 7:99-109

Published Date: 24 April 2015

Internalization: acute apoptosis of breast cancer cells using herceptin-immobilized gold nanoparticles

Rathinaraj P, Al-Jumaily AM, Huh DS

Breast Cancer: Targets and Therapy 2015, 7:51-58

Published Date: 10 February 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010